Valuation: Axogen, Inc.

Market Cap 237.81Cr 208.16Cr 192.15Cr 179.24Cr 337.72Cr 22TCr 343.76Cr 2.3TCr 894.81Cr 11TCr 893.46Cr 873.5Cr 39TCr P/E 2026 *
-115x
P/E 2027 * 290x
Enterprise Value 237.81Cr 208.16Cr 192.15Cr 179.24Cr 337.72Cr 22TCr 343.76Cr 2.3TCr 894.81Cr 11TCr 893.46Cr 873.5Cr 39TCr EV / Sales 2026 *
8.78x
EV / Sales 2027 * 7.47x
Free-Float
96.5%
Yield 2026 *
-
Yield 2027 * -
1 day+3.29%
1 week+2.76%
Current month+17.00%
1 month+17.00%
3 months+47.67%
6 months+38.09%
Current year+41.12%
1 week 41.35
Extreme 41.35
46.26
1 month 38.08
Extreme 38.075
46.26
Current year 27.54
Extreme 27.54
46.26
1 year 10.58
Extreme 10.58
46.26
3 years 3.45
Extreme 3.45
46.26
5 years 3.45
Extreme 3.45
46.26
10 years 3.45
Extreme 3.45
56.85
Manager TitleAgeSince
Chief Executive Officer 66 09/08/2024
Director of Finance/CFO 42 12/05/2025
Chief Operating Officer 65 10/01/2025
Director TitleAgeSince
Director/Board Member 65 01/09/2016
Director/Board Member 58 15/05/2019
Chairman 70 09/08/2024
Date Insider Type Main position Quantity % Market Cap.
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+3.29%+2.76%+339.90%+411.52% 237.81Cr
-1.00%+8.05%+22.80%-2.53% 19TCr
-2.04%-1.31%-25.49%+17.49% 14TCr
-1.19%+6.90%-4.19%-19.89% 14TCr
-1.84%-3.72%-59.94%-19.91% 6.46TCr
-0.79%+5.33%+15.66%-1.70% 5.25TCr
+0.41%-0.87%-27.08%-32.38% 4.34TCr
+0.19%+5.01%+11.46%+12.52% 3.75TCr
+1.67%+4.69%+6.42%+43.17% 3.62TCr
-1.60%+5.56%-13.94%-18.65% 2.96TCr
Average -0.03%+3.97%+26.56%+38.96% 7.35TCr
Weighted average by Cap. -0.61%+5.66%-4.24%-1.36%

Financials

2026 *2027 *
Net sales 27Cr 24Cr 22Cr 20Cr 38Cr 2.56TCr 39Cr 262.54Cr 101.92Cr 1.26TCr 101.77Cr 99Cr 4.4TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.01TCr 46Cr 308.61Cr 119.81Cr 1.49TCr 119.63Cr 116.96Cr 5.18TCr
Net income -2.12Cr -1.85Cr -1.71Cr -1.6Cr -3.01Cr -200.17Cr -3.06Cr -21Cr -7.97Cr -99Cr -7.95Cr -7.78Cr -344.11Cr 80.57L 70.52L 65.1L 60.72L 1.14Cr 76Cr 1.16Cr 7.81Cr 3.03Cr 38Cr 3.03Cr 2.96Cr 130.96Cr
Net Debt - -
Logo Axogen, Inc.
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Employees
622
Date Price Change Volume
01/26/01 $46.19 +3.29% 12,01,680
29/26/29 $44.72 -0.47% 11,67,237
26/26/26 $44.93 +0.99% 32,80,197
25/26/25 $44.49 +4.63% 16,13,230
24/26/24 $42.52 -4.86% 21,33,946
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
46.19USD
Average target price
50.78USD
Spread / Average Target
+9.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AXGN Stock